IRF9 Antikörper
-
- Target Alle IRF9 Antikörper anzeigen
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IRF9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Monoclonal Antibody to Interferon Regulatory Factor 9 (IRF9)
- Spezifität
- The antibody is a mouse monoclonal antibody raised against IRF9. It has been selected for its ability to recognize IRF9 in immunohistochemical staining and western blotting.
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Top Product
- Discover our top product IRF9 Primärantikörper
-
anti-Interferon Regulatory Factor 9 (IRF9) (AA 75-104) antibody
IRF9 Reaktivität: Human, Maus WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 75-104) antibodyIRF9 Reaktivität: Human, Maus WB, IF, IHC (p) Wirt: Kaninchen Polyclonal RB19229 unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 Reaktivität: Human WB, ELISA, IHC (p) Wirt: Maus Monoclonal 1C10 unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) antibodyIRF9 Reaktivität: Human IF, FACS Wirt: Maus Monoclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 101-200) antibodyIRF9 Reaktivität: Human WB, ELISA, IF (cc), IF (p), IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 171-393) antibodyIRF9 Reaktivität: Human WB, IHC, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 44-180) antibodyIRF9 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-394) antibodyIRF9 Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 1C10 unconjugated
-
- Applikationshinweise
- Western blotting: 0.2-2 μg/mL,1:500-5000 Immunohistochemistry: 5-20 μg/mL,1:50-200 Immunocytochemistry: 5-20 μg/mL,1:50-200 Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
- Target
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
- Andere Bezeichnung
- IRF9 (IRF9 Produkte)
- Hintergrund
- ISGF3G, ISGF3, p48, Interferon-Stimulated Transcription Factor 3,Gamma 48 kDa, IFN-alpha-responsive transcription factor subunit, Interferon-stimulated gene factor 3 gamma
- UniProt
- Q00978
- Pathways
- JAK-STAT Signalweg, Interferon-gamma Pathway, Hepatitis C
-
